Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Bach

Showing results (151-160 of 202) with videos related to

Pageof 21
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Association Between Clinical Value and Financial Cost of Cancer Treatments: A Cross-Sectional AnalysisAaron P Mitchell, Sara M Tabatabai, Pranammya Dey, et al.
JAMA|March 8, 2007
Computed tomography screening and lung cancer outcomesPeter B Bach, James R Jett, Ugo Pastorino, et al.
Pharmacoeconomics|March 24, 2020
The Accuracy and Usefulness of the National Comprehensive Cancer Network Evidence Blocks Affordability RatingAaron P Mitchell, Pranammya Dey, Jennifer A Ohn, et al.
JNCI Cancer Spectrum|June 2, 2024
Trends in financial payments from industry to US cancer centers, 2014-2021Nirjhar Chakraborty, Meredith Brown, Sonia Persaud, et al.
JAMA Oncology|May 1, 2018
Delays in the Publication of Important Clinical Trial Findings in OncologyLindor Qunaj, Raina H Jain, Coral L Atoria, et al.
BMJ (Clinical Research Ed.)|October 25, 2023
Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort studyAaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza, et al.
Journal of the National Cancer Institute|October 1, 2021
Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate CancerAaron P Mitchell, Akriti Mishra Meza, Katherine S Panageas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologistsRena M Conti, Arielle C Bernstein, Victoria M Villaflor, et al.
Journal of the National Cancer Institute|July 10, 2008
Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosisElena B Elkin, Nicole Ishill, Gerald F Riley, et al.
Infection Control and Hospital Epidemiology|August 21, 2002
Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemiaPeter B Bach, Sharp F Malak, Joseph Jurcic, et al.
Pageof 21

Showing results (151-160 of 202) with videos related to

Sort By:
Pageof 21
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Association Between Clinical Value and Financial Cost of Cancer Treatments: A Cross-Sectional AnalysisAaron P Mitchell, Sara M Tabatabai, Pranammya Dey, et al.
JAMA|March 8, 2007
Computed tomography screening and lung cancer outcomesPeter B Bach, James R Jett, Ugo Pastorino, et al.
Pharmacoeconomics|March 24, 2020
The Accuracy and Usefulness of the National Comprehensive Cancer Network Evidence Blocks Affordability RatingAaron P Mitchell, Pranammya Dey, Jennifer A Ohn, et al.
JNCI Cancer Spectrum|June 2, 2024
Trends in financial payments from industry to US cancer centers, 2014-2021Nirjhar Chakraborty, Meredith Brown, Sonia Persaud, et al.
JAMA Oncology|May 1, 2018
Delays in the Publication of Important Clinical Trial Findings in OncologyLindor Qunaj, Raina H Jain, Coral L Atoria, et al.
BMJ (Clinical Research Ed.)|October 25, 2023
Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort studyAaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza, et al.
Journal of the National Cancer Institute|October 1, 2021
Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate CancerAaron P Mitchell, Akriti Mishra Meza, Katherine S Panageas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologistsRena M Conti, Arielle C Bernstein, Victoria M Villaflor, et al.
Journal of the National Cancer Institute|July 10, 2008
Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosisElena B Elkin, Nicole Ishill, Gerald F Riley, et al.
Infection Control and Hospital Epidemiology|August 21, 2002
Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemiaPeter B Bach, Sharp F Malak, Joseph Jurcic, et al.
Pageof 21